The safety of Tience treatment has been studied for over 15 years as part of scientific research and product development.
In clinical studies conducted in humans, Tience has been shown to be well tolerated and safe. No allergic reactions, skin irritation or long-term adverse effects have been observed in the studies. By 2026, Tience has been used in over 2,000 treatments without Tience-related adverse effects. For this reason, Tience treatments can be safely performed even on the most delicate skin areas, such as the under-eye area.
Tience is manufactured and in accordance with the EU Tissues and Cells Directive and the regulations of the Finnish Medicines Agency (Fimea), and treatments are performed by trained healthcare professionals.